Cited by 32Neuroscience and Neuropharmacology ResearchProtein Kinase Regulation and GTPase SignalingGenetics and Neurodevelopmental Disorders

An essential role for inhibitor-2 regulation of protein phosphatase-1 in synaptic scaling

Open access
Siddoway, B. A., Altimimi, H. F., Hou, H., Petralia, R. S., Xu, B., Stellwagen, D., Xia, H.·2013·Journal of Neuroscience

Abstract

Protein phosphatase-1 (PP1) activity is important for many calcium-dependent neuronal functions including Hebbian synaptic plasticity and learning and memory. PP1 activity is necessary for the induction of long-term depression, whereas downregulation of PP1 activity is required for the normal induction of long-term potentiation. However, how PP1 is activated is not clear. Moreover, it is not known whether PP1 plays a role in homeostatic synaptic scaling, another form of synaptic plasticity which functions to reset the neuronal firing rate in response to chronic neuronal activity perturbations. In this study, we found that PP1 inhibitor-2 (I-2) is phosphorylated at serine 43 (S43) in rat and mouse cortical neurons in response to bicuculine application. Expression of I-2 phosphorylation-blocking mutant I-2 (S43A) blocked the dephosphorylation of GluA2 at serine 880, AMPA receptor trafficking, and synaptic downscaling induced by bicuculline application. Our data suggest that the phosphorylation of I-2 at S43 appears to be mediated by L-type calcium channels and calcium/calmodulin-dependent myosin light-chain kinase. Our work thus reveals a novel calcium-induced PP1 activation pathway critical for homeostatic synaptic plasticity.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.5241-12.2013

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Dephosphorylation of GluA2 S880 during scaling-down is mediated by activation of phosphatase PP1 through its regulatory protein inhibitor 2 (I-2), while dephosphorylation of GluA2 Y876 requires an upregulation of STEP61.

    “Dephosphorylation of GluA2 S880 during scaling-down is mediated by activation of phosphatase PP1, through its regulatory protein inhibitor 2 (I-2) (Siddoway et al., 2013), while dephosphorylation of GluA2 Y876 requires an upregulation of STEP61 (Jang et al., 2015).”

    From The AMPA Receptor Code of Synaptic Plasticity (2018) · cites this paper as Siddoway et al., 2013

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 31

  1. Bito H, Deisseroth K, Tsien RW (1996) CREB phosphorylation and dephos- phorylation: a Ca 2ϩ and stimulus duration-dependent switch for hip- pocampal gene expression. Cell 87:1203-1214. CrossRef Medline · DOI
  2. Blitzer RD, Connor JH, Brown GP, Wong T, Shenolikar S, Iyengar R, Landau EM (1998) Gating of CaMKII by cAMP-regulated protein phosphatase activity during LTP. Science 280:1940 -1942. CrossRef Medline · DOI
  3. Ceulemans H, Bollen M (2004) Functional diversity of protein phosphatase-1, a cellular economizer and reset button. Physiol Rev 84:1-39. CrossRef Medline · DOI
  4. Chung HJ, Qian X, Ehlers M, Jan YN, Jan LY (2009) Neuronal activity reg- ulates phosphorylation-dependent surface delivery of G-protein- activated inwardly rectifying potassium channels. Proc Natl Acad Sci U S A 106:629 -634. CrossRef Medline · DOI
  5. Cohen P (1989) The structure and regulation of protein phosphatases. Annu Rev Biochem 58:453-508. CrossRef Medline · DOI
  6. Fu AK, Hung KW, Fu WY, Shen C, Chen Y, Xia J, Lai KO, Ip NY (2011) APC(Cdh1) mediates EphA4-dependent downregulation of AMPA re- ceptors in homeostatic plasticity. Nat Neurosci 14:181-189. CrossRef Medline · DOI
  7. Glausier JR, Maddox M, Hemmings HC Jr, Nairn AC, Greengard P, Muly EC (2010) Localization of dopamine-and cAMP-regulated phospho- protein-32 and inhibitor-1 in area 9 of Macaca mulatta prefrontal cortex. Neuroscience 167:428 -438. CrossRef Medline · DOI
  8. Goold CP, Nicoll RA (2010) Single-cell optogenetic excitation drives ho- meostatic synaptic depression. Neuron 68:512-528. CrossRef Medline · DOI · Paper page
  9. Herzog KH, Chong MJ, Kapsetaki M, Morgan JI, McKinnon PJ (1998) Re- quirement for ATM in ionizing radiation-induced cell death in the devel- oping central nervous system. Science 280:1089 -1091. CrossRef Medline · DOI
  10. Hu JH, Park JM, Park S, Xiao B, Dehoff MH, Kim S, Hayashi T, Schwarz MK, Huganir RL, Seeburg PH, Linden DJ, Worley PF (2010) Homeostatic scaling requires group I mGluR activation mediated by Homer1a. Neuron 68:1128 -1142. CrossRef Medline · DOI
  11. Hu XD, Huang Q, Roadcap DW, Shenolikar SS, Xia H (2006) Actin- associated neurabin-protein phosphatase-1 complex regulates hip- pocampal plasticity. J Neurochem 98:1841-1851. CrossRef Medline · DOI
  12. Hu XD, Huang Q, Yang X, Xia H (2007) Differential regulation of AMPA receptor trafficking by neurabin-targeted synaptic protein phosphatase-1 in synaptic transmission and long-term depression in hippocampus. J Neurosci 27:4674 -4686. CrossRef Medline · DOI
  13. Jakawich SK, Neely RM, Djakovic SN, Patrick GN, Sutton MA (2010) An essential postsynaptic role for the ubiquitin proteasome system in slow homeostatic synaptic plasticity in cultured hippocampal neurons. Neu- roscience 171:1016 -1031. CrossRef Medline · DOI
  14. Jouvenceau A, He ´dou G, Potier B, Kollen M, Dutar P, Mansuy IM (2006) Partial inhibition of PP1 alters bidirectional synaptic plasticity in the hippocampus. Eur J Neurosci 24:564 -572. CrossRef Medline · DOI
  15. Kim J, Dittgen T, Nimmerjahn A, Waters J, Pawlak V, Helmchen F, Schlesinger S, Seeburg PH, Osten P (2004) Sindbis vector SINrep (nsP2S726): a tool for rapid heterologous expression with attenuated cy- totoxicity in neurons. J Neurosci Methods 133:81-90. CrossRef Medline · DOI
  16. Li M, Stefansson B, Wang W, Schaefer EM, Brautigan DL (2006) Phosphor- ylation of the pro-X-thr-pro site in phosphatase inhibitor-2 by cyclin- dependent protein kinase during M-phase of the cell cycle. Cell Signal 18:1318 -1326. CrossRef Medline · DOI
  17. Lukas TJ, Mirzoeva S, Slomczynska U, Watterson DM (1999) Identification of novel classes of protein kinase inhibitors using combinatorial peptide chemistry based on functional genomics knowledge. J Med Chem 42: 910 -919. CrossRef Medline · DOI
  18. Morishita W, Marie H, Malenka RC (2005) Distinct triggering and expres- sion mechanisms underlie LTD of AMPA and NMDA synaptic responses. Nat Neurosci 8:1043-1050. CrossRef Medline · DOI
  19. Mulkey RM, Herron CE, Malenka RC (1993) An essential role for protein phos- phatases in hippocampal long-term depression. Science 261:1051-1055. CrossRef Medline · DOI · Paper page
  20. O'Brien RJ, Kamboj S, Ehlers MD, Rosen KR, Fischbach GD, Huganir RL (1998) Activity-dependent modulation of synaptic AMPA receptor ac- cumulation. Neuron 21:1067-1078. CrossRef Medline · DOI · Paper page
  21. Pak DT, Sheng M (2003) Targeted protein degradation and synapse remod- eling by an inducible protein kinase. Science 302:1368 -1373. CrossRef Medline · DOI
  22. Petralia RS, Wang YX, Hua F, Yi Z, Zhou A, Ge L, Stephenson FA, Wenthold RJ (2010) Organization of NMDA receptors at extrasynaptic locations. Neuroscience 167:68 -87. CrossRef Medline · DOI
  23. Qiu Z, Sylwestrak EL, Lieberman DN, Zhang Y, Liu XY, Ghosh A (2012) The Rett syndrome protein MeCP2 regulates synaptic scaling. J Neurosci 32: 989 -994. CrossRef Medline · DOI
  24. Sakagami H, Kondo H (1995) Molecular cloning of the cDNA for rat phos- phatase inhibitor-2 and its wide gene expression in the central nervous system. J Chem Neuroanat 8:259 -266. CrossRef Medline · DOI
  25. Seeburg DP, Feliu-Mojer M, Gaiottino J, Pak DT, Sheng M (2008) Critical role of CDK5 and polo-like kinase 2 in homeostatic synaptic plasticity during elevated activity. Neuron 58:571-583. CrossRef Medline · DOI
  26. Silva AJ, Josselyn SA (2002) The molecules of forgetfulness. Nature 418: 929 -930. CrossRef Medline · DOI
  27. States BA, Khatri L, Ziff EB (2008) Stable synaptic retention of serine-880- phosphorylated GluR2 in hippocampal neurons. Mol Cell Neurosci 38: 189 -202. CrossRef Medline · DOI
  28. Tang X, Hui ZG, Cui XL, Garg R, Kastan MB, Xu B (2008) A novel ATM- dependent pathway regulates protein phosphatase 1 in response to DNA damage. Mol Cell Biol 28:2559 -2566. CrossRef Medline · DOI
  29. Turrigiano GG, Leslie KR, Desai NS, Rutherford LC, Nelson SB (1998) Activity-dependent scaling of quantal amplitude in neocortical neurons. Nature 391:892-896. CrossRef Medline · DOI · Paper page
  30. Wu J, Petralia RS, Kurushima H, Patel H, Jung MY, Volk L, Chowdhury S, Shepherd JD, Dehoff M, Li Y, Kuhl D, Huganir RL, Price DL, Scannevin R, Troncoso JC, Wong PC, Worley PF (2011) Arc/Arg3.1 regulates an en- dosomal pathway essential for activity-dependent beta-amyloid genera- tion. Cell 147:615-628. CrossRef Medline · DOI
  31. Zhong X, Li H, Chang Q (2012) MeCP2 phosphorylation is required for modulating synaptic scaling through mGluR5. J Neurosci 32:12841- 12847. CrossRef Medline · DOI

Cited by

Sorted by citations

Authors
Siddoway, B. A., Altimimi, H. F., Hou, H., Petralia, R. S., Xu, B., Stellwagen, D., & Xia, H.
Affiliations
  • Louisiana State University (US)
  • McGill University (CA)
  • National Institutes of Health (US)
  • Southern Research Institute (US)
Venue
Journal of Neuroscience
Published
2013-07-03
Volume
33
Issue
27
Pages
11206-11211
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W2094995262
Cited by
32
References
3
Citations by year
2026: 1 · 2022: 3 · 2021: 2 · 2020: 5 · 2019: 3 · 2018: 7 · 2017: 1 · 2016: 2 · 2015: 3 · 2014: 4 · 2013: 1
FWCI
1.64
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Science Foundation (0824393)
  • Heart and Stroke Foundation of Canada
  • National Alliance for Research on Schizophrenia and Depression (2006YI)
  • National Institutes of Health
  • Canadian Institutes of Health Research
  • Natural Sciences and Engineering Research Council of Canada
  • National Institute on Deafness and Other Communication Disorders
  • National Institute of Neurological Disorders and Stroke (R01NS060879)
  • National Institute of Environmental Health Sciences (R01ES016354)
  • Division of Integrative Organismal Systems
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Keywords
protein phosphatase 1, homeostatic synaptic scaling, synaptic plasticity, AMPA receptor trafficking, bicuculline, L-type calcium channels, cortical neurons, long-term depression, long-term potentiation
MeSH terms
Protein Phosphatase Inhibitory Proteins, Animals, Animals, Newborn, Cells, Cultured, Homeostasis, Synaptic Transmission, Proteins, Synapses, Rats, Sprague-Dawley, Mice, Knockout, Calcium Channels, L-Type, Mice, Rats, Protein Phosphatase 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review